Objectives: Ultrafast and whole-body cooling can be induced by total liquid ventilation with temperature-controlled perfluorocarbons. Our goal was to determine whether this can afford maximal cardio-and neuroprotections through cooling rapidity when coronary occlusion is complicated by cardiac arrest. Design: Prospective, randomized animal study. Setting: Academic research laboratory. Subjects: Male New Zealand rabbits. Interventions: Chronically instrumented rabbits were submitted to coronary artery occlusion and ventricular fibrillation. After 8 minutes of cardiac arrest, animals were resuscitated and submitted to a normothermic follow-up (control group) or to 3 hours of mild hypothermia induced by total liquid ventilation (total liquid ventilation group) or by combination of cold saline infusion and cold blankets application (saline group). Coronary reperfusion was permitted 40 minutes after the onset of occlusion. After awakening, rabbits were followed up during 7 days. Measurements and Main Results: Ten animals were resuscitated in each group. In the control group, all animals secondarily died of cardiac/respiratory failure (8 of 10) or neurological dysfunction (2 of 10). In the saline group, the target temperature of 32°C was achieved within 30-45 minutes after cooling initiation. This slightly reduced infarct size versus control (41% ± 16% vs 54% ± 8% of risk zone, respectively; p < 0.05) but failed to significantly improve cardiac output, neurological recovery, and survival rate (three survivors, six death from cardiac/respiratory failure, and one from neurological dysfunction). Conversely, the 32°C temperature was achieved within 5-10 minutes in the total liquid ventilation group. This led to a dramatic reduction in infarct size (13% ± 4%; p < 0.05 vs other groups) and improvements in cardiac output, neurological recovery, and survival (eight survivors, two deaths from cardiac/respiratory failure). Conclusions: Achieving hypothermia rapidly is critical to improve the cardiovascular outcome after cardiac arrest with underlying myocardial infarction. (Crit Care Med 2013; 41:e457-e465) 
hypothermia provides neuroprotection (2) , whereas percutaneous coronary intervention is intended for revascularization during coronary artery occlusion (CAO) (3) . Since hypothermia also decreases myocardial susceptibility to ischemia (4) (5) (6) , it could potentiate the cardioprotective effect of reperfusion therapies and further improve hemodynamics when cardiac arrest is associated with coronary obstruction. This cardiac benefit could however be compromised if hypothermia is only achieved into the coronary reperfusion phase (4) (5) (6) , supporting the importance of cooling the heart quickly. This importance has also been evidenced for the neurological effect of hypothermia in animal models of global (7-10) and brain (11) ischemia. Here, we hypothesize that rapidity of cooling is also critical to achieve maximal protection and to prevent cardiovascular mortality when cardiac arrest is combined with CAO.
In order to investigate the importance of the cooling rate, we previously studied ultrafast cooling through total liquid ventilation (TLV). It consists in the tidal ventilation of lungs with temperature-controlled perfluorocarbons that can cool the body while maintaining gas exchanges (12) . After global ischemia, TLV provided a greater neurological benefit and survival improvement than a conventional cooling in a rabbit model (12) . The superiority of TLV was also shown regarding infarct size reduction in rabbits submitted to CAO (5, 6, 13) . Importantly, these previous studies were conducted in pure models of cardiac arrest or CAO but they did not reproduce the complex interactions occurring in vivo during their combination, as often observed in patients (1, 3) .
In the present study, we aimed to determine whether cooling rapidity, assessed by comparison of TLV with a conventional "load-dependent" hypothermia (cold saline infusion plus external cooling), could be actually critical to achieve maximal cardiac, neurological, and survival benefits after combined cardiac arrest and CAO in chronically instrumented rabbits.
MATERIALS AND METHODS
The experiments were conducted in accordance with French official regulations, after approval by the local ethical review board. They conformed to the "Position of the American Heart Association on research animal use."
Animal Preparation
Male New Zealand rabbits were anesthetized using zolazepam, tiletamine, and pentobarbital (all 20-30 mg/kg IV). They were chronically instrumented with a pericoronary pneumatic occluder, an aortic cardiac output probe (PS-Series Probes, Transonic, NY), and an electrode upon the chest.
Coronary Occlusion, Cardiac Arrest, and Cardiopulmonary Resuscitation
Two weeks after surgery, animals were reanesthetized, intubated, and mechanically ventilated (Fio 2 = 100%; V t = 10 mL/kg; 26 breaths/min). The pericoronary occluder was inflated to induce CAO. Two minutes later, ventricular fibrillation was induced by passing an alternating current (10 V, 4 mA) between the chest electrode and another electrode within the esophagus. After 8 minutes of untreated fibrillation, cardiopulmonary resuscitation was started using manual lateral chest compressions (~200 compressions/min), electric attempts of defibrillation (5-10 J/kg), and IV administration of epinephrine (15 µg/kg IV). Mechanical ventilation was stopped throughout the cardiac arrest period and restarted at the onset of cardiopulmonary resuscitation. Resumption of spontaneous circulation (ROSC) was considered as an organized cardiac rhythm associated with a mean arterial pressure above 40 mm Hg during at least 1 minute. Coronary reperfusion was permitted through occluder deflation after 40 minutes of CAO. After ROSC, administration of epinephrine was permitted during 7 hours to maintain mean arterial pressure at ~80 mm Hg. Mechanical ventilation was continued until awakening of the animals.
Experimental Protocol
After ROSC, rabbits randomly underwent life support under normothermic conditions (control group) or with therapeutic hypothermia (TLV and saline groups) ( Fig. 1) . In the TLV group, hypothermia was induced by 20 minutes of liquid ventilation after filling the lungs with 10 mL/kg of perfluorodecalin, as previously described (5, 6, 12, 13) . The liquid ventilator was set initially to a respiratory rate of 6 breaths/min and a tidal volume of ~7-10 mL/kg. If necessary, ventilatory variables were adjusted to maintain saturation of peripheral oxygen (Spo 2 ) over 90%. The temperature of perfluorocarbon was initially set at 20°C and progressively increased to 32°C to maintain oesophageal temperatures at ~32°C. After 20 minutes of TLV, animals resumed to conventional gas ventilation. In the saline group, hypothermia was induced by cold blankets over the skin and infusion of cold (4°C) saline (NaCl 0.9%, 30 mL/kg IV over 30 min). In both saline and TLV groups, hypothermia was maintained externally at 32°C during 3 hours after the onset of the cooling protocol. Subsequently, animals were actively rewarmed using thermal pads and infrared lights until weaning from conventional ventilation and awakening.
Investigated Variables
Hemodynamic variables were continuously recorded using external electrocardiogram, blood pressure in the ear artery, and cardiac output flowmeter (Flowmeter-T206, Transonic, NY). Throughout the 7 days following cardiac arrest, the animals underwent a regular survival and clinical follow-up.
Neurological dysfunction was assessed using a previously described score system (0-10% = normal; 100% = brain death) (12, 14) . In accordance with the ethical committee, the animals showing a neurological dysfunction score above 60% during 48 hours were euthanized and considered as dead from neurological dysfunction. At the end of the 7 days of follow-up, surviving rabbits were reanesthetized and a pressure catheter (SciSense, London, ON, Canada) was introduced into the left ventricle for measurement of end-diastolic pressure and left ventricular rate of pressure development. These variables were also measured in a group of sham rabbits submitted to neither cardiac arrest nor hypothermia.
Postmortem Analysis
Seven days after cardiac arrest, surviving animals were euthanized for organ sampling. Pathological analyses were also conducted in the animals that died prematurely. In the heart, risk zone and infarct sizes were determined using triphenyltetrazolium chloride staining (5, 13) . In all organs, the lesion severity was assessed by histology and quantified using a 0-3 score system (12) . For the brain, a neuropathologist semiquantitatively and blindly assessed the amount of ischemic neurons in the cortex, hippocampus, and cerebellum, as previously described (12) . The brain score was the mean value obtained for these three areas. For lungs, we assessed two separate scores for cardiogenic lesions (serous edema and/or congestion) and infectious complication of bronchopneumonia, respectively (12) . In the myocardium, these analyses were performed in a remote area, out of the risk zone.
Statistical Analyses
Data were expressed as mean ± sd. The normality of data distribution was tested using the Kolmogorov-Smirnov analysis. For normally distributed variables, comparisons were made between groups using a one-way analysis of variance at selected time points as the number of animals varied among time. Post hoc analyses were performed using the Fisher least significant difference method. For nonnormally distributed variables, neurological dysfunction, and histological scores, comparisons were made using a nonparametric Kruskall-Wallis test followed by a Mann-Whitney analysis. Survival curves were obtained using a Kaplan-Meier analysis and compared between groups using a log-rank test. Significant differences were determined at p values less than or equal to 0.05.
RESULTS
Out of the 40 rabbits submitted to cardiac arrest, 30 animals were successfully resuscitated and included in the final experimental groups (n = 10/group). The time to ROSC was 2.9 ± 0.8, 2.8 ± 1.4, and 3.1 ± 1.4 minutes in control, TLV, and saline groups, respectively. Temperatures decreased very rapidly after the onset of cooling in TLV as compared with saline group (Fig. 2) .
TLV Prevents Early Hemodynamic Dysfunction
As illustrated in Figure 3 , TLV reduced left ventricular dysfunction after resuscitation. After 30 minutes of CAO, cardiac output and stroke volumes were indeed increased in TLV versus control and saline groups. Heart rate was conversely decreased throughout hypothermia in both TLV and saline groups ( Table 1) . One day after cardiac arrest, cardiac output was again increased in survivors of the TLV group as compared with control and saline groups. Hypothermia also decreased the amount of epinephrine required to maintain mean arterial pressure at ~80 mm Hg after cardiac arrest (336 ± 209, 305 ± 153 vs 751 ± 488 µg/kg in TLV and saline vs control groups, respectively; p < 0.05). Troponin I blood release was also dramatically attenuated in TLV versus control and saline groups ( Table 2) .
TLV Improves Cardiovascular Outcome and Provides Cardioprotection
As shown in Figure 4, A and B , the hemodynamic improvements observed in the TLV group was associated with a reduced mortality, in particular from cardiovascular and/or respiratory failures. Seven days after cardiac arrest, the survival rate achieved 80% in TLV group versus 0% and 30% in control and saline groups, respectively. As shown in Table 3 , left ventricular performance was not altered in survivors of the TLV group as compared with sham animals, suggesting a complete recovery. Conversely, a pattern of heart failure was observed in the two surviving rabbits of the saline group. Despite similar risk zone sizes in all groups (35% ± 7%, 34% ± 6%, and 40% ± 6% of the left ventricle), the functional benefit of TLV was combined to a potent reduction in infarct size versus saline and control groups (Fig. 5A) . Myocardial necrosis out of the risk zone was also significantly limited by TLV as compared with control and saline groups (Fig. 5B-D) .
TLV Limits Lung Cardiogenic Lesions
As shown in Table 4 , a metabolic acidosis was observed in all groups after cardiac arrest. One hour after coronary reperfusion, blood Po 2 and pH were improved in TLV versus control and saline groups. At necropsy, lung examination showed reduced lung cardiogenic lesions in TLV versus control and saline ( Fig. 6A-C) . Foam macrophages were identified in the TLV group in 8 of 10 animals (Fig. 6D) , probably as a consequence of some perfluorocarbons persistence. Kidney and liver dysfunctions and lesions were moderate in all groups ( Table 2 and Fig. 6E-H) .
TLV Limits Neurological Dysfunction
As illustrated in Figure 7A , the neurological deficit score was significantly attenuated in the TLV group as compared with control and saline groups. This neuroprotective effect was also supported by limited brain ischemic lesions in TLV versus control and saline groups (Figure 7, B and C) . Large cerebral infarctions were observed in two rabbits from the control and saline groups, as well as one small and deep infarction in the TLV group.
DISCUSSION
In the present study, we demonstrate that hypothermic TLV not only attenuates neurological injury and myocardial infarct size but also prevents acute cardiovascular dysfunction and mortality after combined CAO and cardiac arrest. The favorable effect of TLV was related to cooling rapidity as a slower cooling was not similarly efficient, despite similar target temperature (32°C). In this study, we observed a severe postcardiac arrest syndrome (1) with an intense cardiovascular dysfunction as acute CAO and cardiac arrest were associated. In control conditions, mortality within the first 24 hours reached 60% while it was only 30% in a previous report in a similar rabbit model with 10 minutes of shockable cardiac arrest without CAO (12). This model is especially relevant for evaluation of acute heart failure and myocardial stunning (15) after cardiac arrest. During the early phase of global stunning (i.e., prior to coronary reperfusion), a favorable effect of ultrafast cooling was evidenced with TLV. This was probably a direct effect of hypothermia on ventricular contractility (16, 17) as previously observed during regional stunning in rabbits submitted to focal myocardial ischemia (5) . In the present study, TLV further allowed an ultimate complete recovery of left ventricular function within the first 24 hours, as probably related to its potent anti-infarct effect. These functional benefits were largely related to the rapidity of cooling because conventional and slower hypothermia did not provide similar effects on cardiac output and cardiovascular mortality. These results are in line with those of Yannopoulos et al (18) , comparing cold saline infusion to endovascular cooling in a swine model of ischemic cardiac arrest. Infarct size reduction was again directly related to the time to reach the target temperature. In comparison, our present study further demonstrates that the rapidity of cooling is not only critical for infarct size reduction but more importantly for prevention of cardiovascular mortality. The hemodynamic improvement afforded by TLV was however poorly predicted by blood lactate levels.
Beyond its beneficial effect on cardiovascular outcomes, this study also evidenced the neuroprotective effect of TLV through enhanced neurological recovery and decreased brain lesions. Conversely, conventional cooling was not as protective, as previously shown in a pure model of ventricular fibrillation (12) . A benefit should however be evidenced with a larger number of animals as even "slow" hypothermia is known to afford a neurological benefit after cardiac arrest, although attenuated as compared with early hypothermia (7) (8) (9) (10) . This clearly contrasts with the cardioprotective effect of hypothermia that is virtually entirely lost when cooling is delayed (4-6). As an example, Knafelj et al (19) did not show any cardioprotective benefit of Saline, hypothermia induced by IV administration of cold saline combined to external cooling. Statistical comparisons were performed only between total liquid ventilation and sham group (no significant difference); one rabbit died in the saline group during anesthesia before catheterization. In order to determine "usual" values, hemodynamic variables were also assessed in eight rabbits that were not previously submitted to cardiac arrest (sham). www.ccmjournal.org e463 slow and externally induced hypothermia in survivors of ventricular fibrillation with ST-elevation acute myocardial infarction (STEMI), whereas cerebral performance category score was significantly improved. Clinical trials testing hypothermia in STEMI patients with no cardiac arrest also showed disappointing results when hypothermia was delayed (20, 21) as compared with more precocious and aggressive cooling (22) . Taken together, all these findings clearly emphasized the major impact of the rapidity of cooling on outcome after combined CAO and cardiac arrest. As also observed in pigs (23, 24) and despite its invasive nature, hypothermic TLV seems to provide additional benefits to postresuscitation care. In the latter studies, some lung toxicity was however observed with the perfluorocarbon Fluorinert FC-77 (3M Company, St. Paul, MN). The current development of liquid ventilators appropriate for human uses will allow confirmation of the present results for a further clinical translation (25) . In the present study, we used perfluorodecalin for TLV as this compound was recently approved for intrapulmonary administration and bronchoalveolar lavage (Perflubronc PFD, Origen, Austin, TX).
Perfluorodecalin is also radiolucent while the well-known perfluorooctylbromide (Perflubronc PFB; Origen, Austin, TX) is opaque on x-ray with potential disadvantages in case a coronary angioplasty is required in future translations. Perfluorodecalin is also a viscous liquid with a low vapor pressure as compared with other perfluorocarbons. It will be necessary to test other perfluorocarbons with a higher vapor pressure and evaporating rate (e.g., perfluorooctane). In the future, it will also be important to confirm the present results in large animals, as small ones poorly mimic human inflammation states (26) , that are known to be critical after cardiac arrest.
The present study has several limitations. First, a limited number of animals were euthanized for ethical reasons before the end of the follow-up (i.e., three control animals). This was conducted after 48 hours of follow-up when certain and rapid death was expected. Our survival analyses therefore took into account spontaneous deaths but also decision to kill highly disabled animals in rare cases. Second, we did not measure coronary perfusion pressure during the cardiac massage. It would be relevant to investigate the massage efficiency. 
